Health in Czechia

1,080 indicators covering health for Czechia.

IndicatorLatest Year10-yr change Rank
Mean HDL cholesterol, age-standardized 1.5 2018 up 7.1% 3rd
Mean total cholesterol, crude 5.2 2018 down 1.9% 3rd
Mean Non-HDL cholesterol, age-standardized 3.5 2018 down 5.4% 51st
Mean HDL cholesterol, crude 1.5 2018 up 7.1% 3rd
Mean Non-HDL cholesterol, crude 3.7 2018 down 5.1% 18th
Mean total cholesterol, age-standardized 5 2018 down 3.8% 10th
Infant mortality rates by NUTS 2 region 2.3 2024 down 4.2% 28th
Prevalence of anemia among children 18.7% 2019 up 16.9% 146th
Life expectancy by age, sex and NUTS 2 region 80.1 2024 up 1.6% 26th
Births attended by skilled health staff 99.8% 2017 up 0.1% 30th
Births attended by health staff sdgs 99.8 2017 up 0.1% 30th
Number of deaths among children ages 10 to 14 years 52 2021 down 1.9% 126th
Adolescent mortality rate 0.4468 2021 down 23.4% 168th
Prevalence of current tobacco use 28.4% 2024 down 7.2% 37th
Prevalence of current tobacco use, females 24.6% 2024 down 5.0% 17th
Prevalence of current tobacco use, males 32.2% 2024 down 8.5% 67th
BCG immunization coverage among 1-year-olds (%) 98.0% 2009 unchanged 32nd
Physicians 4.35 per 1,000 people 2022 up 18.4% 22nd
Physicians per 1000 people 4.35 2022 up 18.4% 22nd
Global vaccination coverage 86 2024 down 13.1% 117th
Proportion of population with primary reliance on clean fuels and 99.0% 2024 up 2.1% 29th
Under-five mortality rate, by sex 2.59 per 1,000 live births 2024 down 17.6% 168th
Infant mortality rate 2.1 per 1,000 live births 2024 down 17.1% 170th
Neonatal mortality rate 1.41 per 1,000 live births 2024 down 10.8% 167th
Infant mortality by NUTS 2 region 196 2024 down 25.5% 19th
Number of incident tuberculosis cases 530 2024 down 11.7% 134th
Incidence of tuberculosis 4.9 2024 down 14.0% 165th
Number of incident tuberculosis cases 18 2024 up 350.0% 126th
Number of deaths due to tuberculosis, excluding HIV 37 2024 down 5.1% 131st
Deaths due to tuberculosis among HIV-negative people 0.34 2024 down 10.5% 152nd
Tuberculosis deaths by hiv status 4 2024 up 300.0% 126th
Tuberculosis case fatality rate 8 2024 up 14.3% 122nd
Life satisfaction vs child mortality 6.82 2025 up 3.4% 19th
Incidence of tuberculosis sdgs 4.9 2024 down 14.0% 174th
Tuberculosis deaths region 40 2024 unchanged 133rd
Tuberculosis death rate 0.38 2024 unchanged 169th
Tuberculosis deaths who 40 2024 unchanged 133rd
People using safely managed sanitation services, rural 82.1% 2024 up 1.0% 17th
Tuberculosis incidence 4.9 per 100,000 people 2024 down 14.0% 160th
Tuberculosis patients with hiv share 3.5 2024 up 473.8% 93rd
Life expectancy prados de la escosura 78.57 2020 up 1.3% 36th
Tuberculosis - new and relapse cases 448 2024 down 5.5% 132nd
Tuberculosis treatment coverage 84 2024 up 5.0% 55th
Mean BMI (kg/mΒ²) 27.1 2016 up 1.5% 46th
Rubella - number of reported cases 0 2025 β€” 91st
Treatment success rate: new TB cases 71 2023 up 2.9% 146th
Yellow fever - number of reported cases 0 2025 β€” 26th
Current health expenditure per capita, PPP 4,674 current international $ 2024 up 89.1% 31st
Out-of-pocket expenditure per capita, PPP 657.35 current international $ 2024 up 83.9% 50th
Domestic general government health expenditure 7.1% 2023 up 13.0% 23rd
Domestic private health expenditure per capita, PPP 704.62 current international $ 2023 up 96.3% 61st
Domestic general government health expenditure per capita 2,253 current US$ 2023 up 76.8% 29th
Share of out of pocket expenditure on healthcare 14.06 2024 down 2.7% 148th
Tuberculosis treatment success rate in new and relapsed cases 71 2023 up 2.9% 156th
Share of public expenditure on healthcare by country 84.34 2023 down 0.1% 10th
Private health expenditure per person 704.62 2023 up 96.3% 61st
Public healthcare spending share gdp 7.11 2023 up 13.0% 23rd
Health spending per person by source 3,795 2023 up 94.6% 24th
Poliomyelitis - number of reported cases 0 2018 β€” 8th
Rubella vaccination coverage 89 2024 down 10.1% 103rd